Zhaode Bu

7.1k total citations · 5 hit papers
108 papers, 3.9k citations indexed

About

Zhaode Bu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Zhaode Bu has authored 108 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Pulmonary and Respiratory Medicine, 50 papers in Surgery and 32 papers in Oncology. Recurrent topics in Zhaode Bu's work include Gastric Cancer Management and Outcomes (66 papers), Metastasis and carcinoma case studies (33 papers) and Gastrointestinal Tumor Research and Treatment (29 papers). Zhaode Bu is often cited by papers focused on Gastric Cancer Management and Outcomes (66 papers), Metastasis and carcinoma case studies (33 papers) and Gastrointestinal Tumor Research and Treatment (29 papers). Zhaode Bu collaborates with scholars based in China, Ethiopia and United States. Zhaode Bu's co-authors include Jiafu Ji, Xiaojiang Wu, Xueda Hu, Zemin Zhang, Ranran Gao, Xianwen Ren, Baocai Xing, Ziyu Li, Shishang Qin and Hanqiang Ouyang and has published in prestigious journals such as Science, Cell and Nature Communications.

In The Last Decade

Zhaode Bu

103 papers receiving 3.9k citations

Hit Papers

A pan-cancer single-cell ... 2019 2026 2021 2023 2021 2021 2019 2022 2023 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Zhaode Bu 1.5k 1.3k 1.3k 1.3k 830 108 3.9k
Takaaki Arigami 1.9k 1.2× 1.5k 1.1× 744 0.6× 596 0.5× 935 1.1× 188 3.5k
Hiroshi Kurahara 2.4k 1.6× 936 0.7× 1.3k 1.0× 743 0.6× 948 1.1× 195 4.0k
Jifang Gong 1.7k 1.1× 928 0.7× 785 0.6× 381 0.3× 540 0.7× 147 2.9k
Ravit Geva 4.1k 2.7× 1.6k 1.2× 822 0.6× 1.2k 0.9× 880 1.1× 134 5.3k
Akin Atmaca 2.2k 1.4× 1.4k 1.1× 845 0.7× 505 0.4× 565 0.7× 61 3.3k
Simon Pernot 2.2k 1.5× 1.1k 0.8× 759 0.6× 938 0.7× 547 0.7× 99 3.5k
Kosei Maemura 1.6k 1.1× 832 0.6× 1.1k 0.9× 387 0.3× 933 1.1× 158 3.4k
Yoichi Naito 1.7k 1.1× 1.1k 0.8× 623 0.5× 355 0.3× 284 0.3× 150 2.7k
Satoru Iwasa 2.7k 1.8× 1.9k 1.4× 782 0.6× 352 0.3× 1.3k 1.5× 255 4.4k
Peter Bronsert 1.7k 1.1× 1.2k 0.9× 1.4k 1.1× 271 0.2× 807 1.0× 142 3.9k

Countries citing papers authored by Zhaode Bu

Since Specialization
Citations

This map shows the geographic impact of Zhaode Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaode Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaode Bu more than expected).

Fields of papers citing papers by Zhaode Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaode Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaode Bu. The network helps show where Zhaode Bu may publish in the future.

Co-authorship network of co-authors of Zhaode Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaode Bu. A scholar is included among the top collaborators of Zhaode Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaode Bu. Zhaode Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Si, Wen, Sijin Cheng, Haiyin He, et al.. (2025). SARDH in the 1-C metabolism sculpts the T-cell fate and serves as a potential cancer therapeutic target. Cellular and Molecular Immunology. 22(11). 1363–1378.
2.
Zhang, Xiaolu, et al.. (2024). Challenges and prospects of cell-free DNA in precision oncology. SHILAP Revista de lepidopterología. 1(4). 100059–100059. 1 indexed citations
4.
Wang, Anqiang, Ke Ji, Xin Ji, et al.. (2023). Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases. The Journal of Pathology Clinical Research. 10(1). e343–e343. 4 indexed citations
5.
Sun, Chenglong, Anqiang Wang, Yanhe Zhou, et al.. (2023). Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer. Nature Communications. 14(1). 2692–2692. 164 indexed citations breakdown →
6.
Fu, Tao, Yi Feng, Zhongwu Li, et al.. (2023). Liquid biopsy: circulating tumor DNA monitors neoadjuvant chemotherapy response and prognosis in stage II/III gastric cancer. Molecular Oncology. 17(9). 1930–1942. 6 indexed citations
7.
Ji, Xin, Ke Ji, Ziyu Jia, et al.. (2022). A Practical Nomogram for Predicting the Prognosis of Elderly Patients with Gastric Adenocarcinoma After Gastrectomy. SHILAP Revista de lepidopterología. 3 indexed citations
8.
Zheng, Liangtao, Shishang Qin, Wen Si, et al.. (2021). Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science. 374(6574). abe6474–abe6474. 699 indexed citations breakdown →
9.
Liu, Ziyang, Anqiang Wang, Yingying Pu, et al.. (2021). Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach. Oncogene. 40(38). 5705–5717. 30 indexed citations
10.
Cheng, Sijin, Ziyi Li, Ranran Gao, et al.. (2021). A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 184(3). 792–809.e23. 820 indexed citations breakdown →
11.
Chen, Jiahui, Kai Zhou, Anqiang Wang, et al.. (2021). Effect of Additional Trastuzumab in Neoadjuvant and Adjuvant Treatment for Patients with Resectable HER2-Positive Gastric Cancer. Annals of Surgical Oncology. 28(8). 4413–4422. 11 indexed citations
12.
Zhang, Yinan, Yiqiang Liu, Anqiang Wang, et al.. (2021). Construction and Validation of a Risk-Scoring Model that Preoperatively Predicts Lymph Node Metastasis in Early Gastric Cancer Patients. Annals of Surgical Oncology. 28(11). 6665–6672. 15 indexed citations
13.
Wang, Zhilong, Yanling Li, Lei Tang, et al.. (2020). Utility of the gastric window in computed tomography for differentiation of early gastric cancer (T1 stage) from muscularis involvement (T2 stage). Abdominal Radiology. 46(4). 1478–1486. 9 indexed citations
15.
Li, Lin, Xianzi Wen, Zhaode Bu, et al.. (2016). Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells. Oncology Reports. 35(5). 3009–3017. 18 indexed citations
16.
Shan, Fei, Rulin Miao, Kan Xue, et al.. (2015). Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials. Cancer Letters. 380(2). 598–607. 23 indexed citations
17.
Li, Li, et al.. (2014). Publishing in open access era: focus on respiratory journals.. Europe PMC (PubMed Central). 6 indexed citations
18.
Bu, Zhaode & Jiafu Ji. (2013). A current view of gastric cancer in China. 1–4. 18 indexed citations
19.
Bu, Zhaode, Zhixue Zheng, Ziyu Li, et al.. (2013). Lymphatic vascular invasion is an independent correlated factor for lymph node metastasis and the prognosis of resectable T2 gastric cancer patients. Tumor Biology. 34(2). 1005–1012. 28 indexed citations
20.
Koh, Cherry, Zhaode Bu, Aiwen Wu, et al.. (2011). Neoadjuvant chemotherapy with FOLFOX: Improved outcomes in Chinese patients with locally advanced gastric cancer. Journal of Surgical Oncology. 105(8). 793–799. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026